SCM
CLVS

Sio Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Sio Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,500
Closed -$1.17M – 75
2017
Q2 		$1.17M Buy
+12,500
New +$765K 0.56% 46

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sio Capital Management's CLVS Position: Q3 2017 in Review

Sio Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2017, closing a stake of 12,500 shares — an estimated $1.17M sold.

Sio Capital Management first reported a position in CLVS in Q2 2017 and held it in 1 quarter. The position peaked at $1.17M in Q2 2017. 255 funds tracked by Wall St. Rank hold CLVS as of Q3 2017.

  • Sio Capital Management reported no remaining Clovis Oncology, Inc. position as of Q3 2017 after selling out during the quarter.
  • Sio Capital Management sold 12,500 Clovis Oncology, Inc. shares in Q3 2017, an estimated $1.17M.
  • Sio Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2017 and held it in 1 quarter.
  • Sio Capital Management's Clovis Oncology, Inc. position peaked at $1.17M in Q2 2017.
  • 255 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2017.

Based on Sio Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.